You searched for "CRVO"
It’s not always GCA
Giant cell arteritis (GCA) is an immune mediated granulomatous inflammatory disease that affects muscular middle or large sized arteries. It is considered as a continuation of polymyalgia rheumatica (PMR) when the severity of the disease has increased. It is the...Conference Report: ARVO 2025 Annual Meeting
The Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting was held at the Salt Palace Convention Centre in Salt Lake City, US. This prestigious event brought together experts in vision and ophthalmology from around the world for...
IOP measures after intraocular chemotherapy
This study aimed to describe the relationship between intravitreal chemotherapy and IOP in children with retinoblastoma and identify risk factors for pronounced elevations. This was a retrospective study of ten cases (ten eyes) with 17 encounters overall. Mean age was...
Occult central retinal artery occlusion
1 February 2022
| Kurt Spiteri Cornish
|
EYE - Vitreo-Retinal
|
CRAO, Central retinal artery occlusion, OCT, RAO, optical coherence tomography, retinal artery occlusion, spectral-domain optical coherence tomography
Central retinal artery occlusion (CRAO) is a sight-threatening condition resulting from occlusion of the central retinal artery and hypoperfusion of the inner retina. Early on, fundal examination may be normal. The authors present a retrospective case series of 11 patients...
Intravitreal bevacizumab vs. ranibizumab in the treatment of macular oedema due to BRVO
This is a randomised, prospective, non-inferiority trial of 75 patients with macular oedema due to a branch retinal vein occlusion (BRVO) who received intravitreal injections of ranibizumab or bevacizumab after 1:1 block randomisation. This study is to measure the difference...Obituary: Sohan Singh Hayreh (1927 - 2022)
24 November 2022
Sohan would have been 95 on 6 November this year, but due to complications of COVID-19, he passed away on 29 September.
Does Ozurdex affect perfusion status in vein occlusion?
1 October 2018
| Eulee Seow
|
EYE - Cataract, EYE - Refractive
|
intravitreal dexamethasone implant, peripheral nonperfusion, retinal vein occlusion, wide-field fluorescein angiography
Ozurdex (intravitreal dexamethasone implant) has been approved by National Institute of Health & Care Excellence (NICE) for treatment of patients with macular oedema associated with vein occlusion. This study looks at the change in peripheral perfusion status in patients with...
The ocular manifestations of COVID-19: an overview of current literature
Although respiratory symptoms are the most frequent manifestation of COVID-19, multi-organ involvement has been demonstrated, including ocular manifestations. The author investigates how the eye can be affected. The SARS-CoV-2 virus responsible for the COVID-19 pandemic has presented a significant public...
IVTA for diabetic macular edema and macular edema secondary to retinal vein occlusion: a meta-analysis
1 August 2024
| Sofia Rokerya
|
EYE - Vitreo-Retinal
This meta-analysis aimed to compare the safety and efficacy of different doses of intravitreal triamcinolone acetonide (IVTA) for diabetic macular oedema (DME) and macular oedema (ME) secondary to retinal vein occlusion (RVO). A systematic literature search for randomised controlled trials...
App and web service recommendations
1 April 2019
| David Haider
|
EYE - General
This article offers some app and web service suggestions. A few are new and others well established, but all offer useful features. Messaging for teams Many businesses provide their employees with instant messaging services to allow calling, messaging and collaboration....
Genetic profiling for personalised healthcare solutions in AMD – an update
1 August 2015
| Rod McNeil
|
EYE - Vitreo-Retinal
Age-related macular degeneration (AMD) is a multifactorial condition influenced by genetics and lifestyle factors (Table 1). This article outlines several recent advances in AMD genetics, as well as evolving therapeutic concepts and established practical measures for the treatment and /...
